Resolvyx Pharmaceuticals, Inc. (extinct)

Resolvyx Pharmaceuticals, Inc. (extinct)

Resolvyx Pharmaceuticals, Inc. (extinct)

Overview
Date Founded

2001

Headquarters

25 1st Street,Cambridge, MA 02141

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Biotechnology
Medical Products & Equipment

Company Description

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA.

Paths to Resolvyx Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Resolvyx Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Resolvyx Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Resolvyx Pharmaceuticals, Inc. raised money in a private placement transaction

Investors
Details Hidden

Director at Psychogenics, Inc.

Details Hidden

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Details Hidden

Adjunct Professor of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Resolvyx Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Resolvyx Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Resolvyx Pharmaceuticals, Inc..